Targeted Ferroptosis Improves RPE Phagocytosis via MERTK/NFE2L2/HMOX1 Axis to Alleviate Retinitis Pigmentosa
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.3.42 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Yuwen Wen and 11 co-authors. Institution: State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Zhongshan Ophthalmic Center, Sun Yat-…. Major MEDLINE topics: Retinal Pigment Epithelium, c-Mer Tyrosine Kinase, Ferroptosis, Phagocytosis. Cited 3 times so far (Crossref); 66 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
Retinitis pigmentosa (RP) is a heterogeneous inherited retinal disorder in which progressive rod and cone degeneration, together with retinal pigment epithelium (RPE) dysfunction, culminates in vision loss. Given the lack of effective therapies, we investigated RPE pathogenic alterations in RP models to inform potential therapeutic strategies.
Methods
This study integrates Royal College of Surgeons (RCS) rat in vivo and human primary RPE cells in vitro to investigate the RP model. We employ single-cell RNA sequencing (scRNA-seq) to analyze the transcriptional differences in the retinas of RCS and RDY rats and to interrogate ferroptosis-related signal transduction. After treatment with the ferroptosis inhibitor Ferrostatin-1 (Fer-1) in both in vivo and in vitro RP models, therapeutic efficacy and RPE phagocytic function were assessed by using fundus photography, hematoxylin and eosin staining, electroretinography, Western blotting, immunofluorescence, and reverse transcription quantitative PCR.
Results
Our scRNA-seq revealed marked transcriptional remodeling across retinal cell populations in RCS rats, with ferroptosis-related programs evident in most cell types and most pronounced in RPE. NFE2L2 and HMOX1 were significantly upregulated in RCS rats and in vitro MERTK-deficient RP models. Fer-1 ameliorated cytoskeletal disorganization and restored RPE phagocytic function, whereas selective silencing of NFE2L2 or HMOX1 reduced iron overload and rescued cytoskeletal integrity and phagocytosis, supporting a pathogenic role for ferroptosis in RP.
Conclusions
Ferroptosis is a critical driver of MERTK-deficient RP, influencing RPE dysfunction through the MERTK/NFE2L2/HMOX1 axis. These insights highlight the potential therapeutic strategy of targeting ferroptosis to regulate RPE function in the treatment of MERTK-deficient RP.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
- Shenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, China.
- Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Cite
APA
Wen, Y., Feng, L., Xu, S., Zhang, T., Huang, Z., Du, Y., Zhu, Y., Deng, C., Deng, Y., Su, W., Zhang, S., & Zhuo, Y. (2026). Targeted Ferroptosis Improves RPE Phagocytosis via MERTK/NFE2L2/HMOX1 Axis to Alleviate Retinitis Pigmentosa. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.3.42
Vancouver
Wen Y, Feng L, Xu S, Zhang T, Huang Z, Du Y, et al. Targeted Ferroptosis Improves RPE Phagocytosis via MERTK/NFE2L2/HMOX1 Axis to Alleviate Retinitis Pigmentosa. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.3.42
BibTeX
@article{Wen2026,
author = {Wen, Yuwen and Feng, Lujia and Xu, Shengsong and Zhang, Ting and Huang, Zhaohao and Du, Yong and Zhu, Yingting and Deng, Caibin and Deng, Ye and Su, Wenru and Zhang, Shaochong and Zhuo, Yehong},
title = {Targeted Ferroptosis Improves RPE Phagocytosis via MERTK/NFE2L2/HMOX1 Axis to Alleviate Retinitis Pigmentosa},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.3.42}
}
EUVIMED